First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sees Significant Decrease in Short Interest

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 300 shares, a decline of 25.0% from the April 15th total of 400 shares. Based on an average daily volume of 14,300 shares, the short-interest […]

Related Keywords

,Nasdaq Us Smart Pharmaceuticals ,First Trust Nasdaq Pharmaceuticals ,Outlook Wealth Advisors ,Newedge Advisors ,Foundations Investment Advisors ,Centaurus Financial Inc ,News Ratings For First Trust Nasdaq Pharmaceuticals ,Get Rating ,Trust Nasdaq Pharmaceuticals ,Investment Advisors ,Edge Advisors ,First Trust Nasdaq Pharmaceuticals Etf ,Nasdaq Ftxh ,Ftxh ,Manufacturing ,Stocks ,Options ,Put ,Call ,